Mapping tumor microenvironments to predict lung cancer immunotherapy response

Mapping tumor microenvironments to predict lung cancer immunotherapy response

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells cluster around tumors. Their results reveal that spatial arrangements of certain immune cells within tumors can serve as powerful predictors of treatment response, surpassing existing biomarker tests.